FDA inspection
Dexcom, Inc.: FDA inspection ending Sep 29, 2023
FDA inspection 1220386 · No Action Indicated (NAI) · San Diego, CA
Key facts
| Inspection ID | 1220386 |
|---|---|
| Firm | Dexcom, Inc. |
| FEI number | 3004753838 |
| Address | 6340 Sequence Dr |
| City | San Diego |
| State | CA |
| ZIP | 92121 |
| Country | United States |
| Fiscal year | 2023 |
| Inspection end date | Sep 29, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Compliance: Devices |
| Product type | Devices |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data